Production and proteomic characterisation of purified protein derivative from Mycobacterium avium subsp. paratuberculosis
© Wynne et al; licensee BioMed Central Ltd. 2012
Received: 25 November 2011
Accepted: 26 March 2012
Published: 26 March 2012
Effective diagnosis of Johne's disease (JD), particularly at the stage of early subclinical infection, remains one of the greatest challenges for the control of JD worldwide. The IFN-γ test of cell mediated immunity is currently one of the most suitable diagnostics for subclinical infections, however a major limitation of this test is the lack of a standardised purified protein derivative (PPD) antigen (also referred to as Johnin PPD or PPDj). While attempting to replace PPDj with more specific individual antigens is an attractive proposition, bacterial culture derived PPDj remains the most effective antigen preparation for the diagnosis of subclinical JD. It may be possible to increase the reproducibility and specificity of PPDj preparations by further characterising and standardising the PPDj production.
Using a standardised protocol, five in-house preparations of PPDj were prepared from cultures of Mycobacterium avium subsp. paratuberculosis (MAP). Compared to PPDs obtained from other institutes/laboratories, these preparations appeared to perform similarly well in the IFN-γ test. Although the broad proteomic composition of all PPDj preparations was remarkably similar, the absolute abundance of individual proteins varied markedly between preparations. All PPDj preparations contained common immunogenic proteins which were also observed in PPD preparations from Mycobacterium avium subsp. avium (PPDa) and Mycobacterium bovis (PPDb). Temporal difference in protein secretion of in vitro cultured MAP was observed between 20 and 34 weeks suggesting that the age of MAP culture used for PPDj preparations may markedly influence PPDj composition.
This study describes a protocol for the production of PPDj and its subsequent proteomic characterisation. The broad proteomic composition of different preparations of PPDj was, for the most part, highly similar. Compositional differences between PPDj preparations were found to be a direct reflection of genetic differences between the MAP strain types used to produce these preparations and the age of MAP cultures they were derived from. A number of conserved immunogenic proteins, such as members of the cutinase-like protein family, were found to be more abundant in PPDj compared to PPDa and should be considered as possible diagnostic antigens for the future.
KeywordsJohne's disease Johnin PPD PPDj Interferon gamma Diagnostic antigen Mass spectrometry
Johne's disease (JD) is a significant animal health issue worldwide. JD is a chronic infectious enteritis of wild and domestic ruminants. Caused by the Gram positive, acid fast bacilli, Mycobacterium avium subsp. paratuberculosis (MAP), JD is responsible for significant financial losses to many livestock industries, most notably dairy and beef cattle production . Asymptomatic subclinically infected animals pose a significant challenge for the control and management of JD. From the early stages of infection animals have the ability to excrete large quantities of viable bacilli into the environment which can subsequently reinfect other members of the herd. The accurate diagnosis and eradication of subclinically infected animals is therefore vital for control and management of JD worldwide. Although not proven, MAP may also act as a zoonotic agent in some human diseases [2–4].
A range of diagnostic tests, varying in their sensitivity, specificity and suitability have been trialled for the diagnosis of MAP infections [5–9]. Serological-based tests such as ELISA , gel immuno-diffusion [7, 10] and complement fixation  tests have proven successful for the diagnosis of the clinical stages of disease when a robust antibody response has developed. Serological-based tests, however, have failed to diagnose both early and subclinical stages of infection. Traditionally, the early and subclinical stages of infection were thought to be dominated by cell-mediated immunity (CMI) rather than circulating antibodies . Recent evidence however suggests that JD infected sheep are more likely to have a combined CMI and antibody response during the early stages of infection . The CMI response against MAP is characterised by a Th1-type cellular response leading to the secretion of a number of cytokines, including interferon gamma (IFN-γ) .
Diagnostic tests based on measuring CMI response have proven to be more suitable for the detection of subclinical stages of infection compared to serological-based tests . The most common test of CMI for JD diagnosis relies on the quantification of released IFN-γ following antigenic stimulation of peripheral blood lymphocytes. Originally developed for the diagnosis of bovine tuberculosis (BOVIGAM™) , this IFN-γ test has also been adapted for the diagnosis of subclinical MAP infections across a range of species including cattle [14, 15], sheep  and goats . This test is based on an ELISA and relies on the use of purified protein derivative (PPD) as the stimulating antigen. Johnin PPD (PPDj) is a crude preparation of MAP culture inactivated by heat treatment, precipitated with trichloroacetic acid (TCA) and resuspended in phosphate buffer containing glucose and phenol.
While described in the Australia and New Zealand Standard Diagnostic Procedure (ANZSDP; http://www.scahls.org.au) for JD diagnosis, the IFN-γ test is not routinely used in Australia due to its low specificity to diagnose JD over non-MAP mycobacterial exposure. Indeed, several studies have demonstrated JD infected animals cross react with PPD antigen preparations from Mycobacterium bovis (PPDb) and Mycobacterium avium (PPDa) [6, 15]. Such cross reactivity is most likely due to the presence of common immunogenic proteins conserved across the Mycobacterium genus. Many of these proteins are major components of PPDb and PPDa [16, 17]. Increasing specificity through, either the replacement of PPDj with individual antigens, or refining PPD composition, may greatly improve this diagnostic. PPDj may be refined by simply standardising its production, including using a common MAP reference strain, an optimised harvest time point and production procedure.
Another major drawback of the IFN-γ test, which contributes to its low specificity, concerns the lack of standardised PPDj preparations. While PPDj is now produced by a number of different institutes/laboratories, its potency to induce an IFN-γ response differs significantly between preparations [7, 10, 18]. Consequently the concentration of PPDj antigen used in IFN-γ tests varies considerably between laboratories . Globally, a range of genetically diverse MAP strains have been employed to prepare PPDj . In Canada alone as many as six different MAP strains have been used, some of which have been cultured within the laboratory for many generations . The different MAP strains used to prepare PPDj may significantly contribute to the variability between PPDj preparations. Indeed, strain differences have been shown to significantly alter protein expression profiles. A comparison between the laboratory-adapted reference isolate K10 with a wild type bovine isolate 187 demonstrated the latter has increased expression of a number of proteins compared to K10 . Different MAP strains also demonstrate variation in growth dynamics which may significantly affect the composition of PPDj depending on the harvest time point .
The variable non-standardised nature of PPDj makes comparisons between different laboratories difficult. While attempts to replace PPDj with individual antigens have proven encouraging , PPDj remains the most widely used diagnostic antigen for subclinical JD diagnosis using the IFN-γ assay. We believe that by careful standardisation and characterisation of PPDj it may be possible to improve this diagnostic antigen and also, in the process, identify new antigen targets. To this end, our laboratory has produced PPDj in-house over the past decade following a standardised laboratory protocol. These PPDj preparations have been utilised in a number of published studies and have performed as well as other available PPDj preparations in their ability to diagnose MAP infections [23–25].
In this study we describe a standardised protocol for the production of PPDj within our laboratory. The proteomic composition of these preparations were then characterised by mass spectrometry and compared to a selection of PPD preparations sourced from other institutes/laboratories. Temporal changes in protein secretion of in vitro cultured MAP were also investigated in an attempt to identify the optimal harvest time point for PPDj preparation. Throughout this process a number of potential antigens were identified and these may serve as possible diagnostic markers for JD infection. Such antigens may even offer an alternative to the PPDj in the future.
Results and Discussion
Most common proteins observed in 12 PPDj samples
20 W sec
34 W sec
10 kDa chaperonin
acyl carrier protein
fibronectin-binding antigen 85 complex B
molecular chaperone DnaK
secreted antigen Wag31
integration host factor MihF
phosphoenolpyruvate carboxykinase (GTP)
electron transfer flavoprotein (beta-subunit)
electron transfer flavoprotein (alpha-subunit)
H(+)-transporting two-sector ATPase, alpha subunit
elongation factor Tsf
ribosomal protein L7/L12
peroxiredoxin subunit C
H(+)-transporting two-sector ATPase, beta subunit
Similarity of amino acid sequence of cutinase-like proteins from MAP
Similarity to Mb †
Similarity to MAH ±
Similarity to MAA γ
‡ MAPK_0273/ ¥ MAP_3495c
50% to Mb3751
88% to MAV_2169
100% to MaviaA2_23256
‡ MAPK_0340/ ¥ MAP_3428c
46% to Mb3482
99% to MAV_4283
99% to MaviaA2_18901
‡ MAPK_1464/ ¥ MAP_2304
51% to Mb2006c
99% to MAV_1682
99% to MaviaA2_010100007523
‡ MAPK_1748/ ¥ MAP_2020
55% to Mb1788
96% to MAV_2169
100% to MaviaA2_010100009430
‡ MAPK_2088/ ¥ MAP_1680c
75% to Mb2006c
98% to MAV_2741
99% to MaviaA2_11201
‡ MAPK_3435/ ¥ MAP_0333
78% to Mb3751
100% to MAV_0369
99% to MaviaA2_01656
‡ MAPK_4239/ ¥ MAP_4237c
74% to Mb3481
99% to MAV_4394
99% to MaviaA2_010100019466
Decreasing the inherent cross reactivity against non-MAP mycobacterial antigens remains a significant challenge for improving JD diagnosis. In an attempt to identify proteins which are unique to PPDj, we also characterised the proteomic composition of PPD preparations produced from Mycobacterium avium subsp. avium (PPDa) and Mycobacterium bovis (PPDb). These PPD preparations are commonly used as control antigens in IFN-γ tests to control for antigenic cross reactivity against environmental non-MAP mycobacteria. Interestingly, PPDa contained significantly less proteins compared to PPDj and PPDb (Figure 2). This finding is in agreement with a study by Santema et al.  who demonstrated that the composition of PPDa was significantly less complex compared with PPDj preparations. Nevertheless our study investigated only one PPDa preparation and additional preparations should be examined to confirm this finding. Despite fewer proteins, PPDa was highly similar in composition to PPDj. Interestingly, many of the most common components of PPDj were also identified in PPDa and PPDb (Table 1). MRM analysis demonstrated that PPDa had very similar abundance of the acyl carrier protein acpM compared to PPDj (Figure 4B). Conserved proteins that are shared between different mycobacterial PPD preparations undoubtedly increase the likelihood of cross reactivity. Two proteins that were found to be unique to PPDj are the peroxiredoxin subunits C and D (ahpC and ahpD). These proteins have been evaluated as potential diagnostic antigens previously and have been shown to be specific to MAP with little cross reactivity against other mycobacteria [28, 29]. A recent review by Mikkelsen et al.  suggests ahpC and ahpD are two of the most promising antigens for measuring specific cell mediated immunity. Other proteins which were common in PPDj, but absent in PPDa and PPDb include phosphoenolpyruvate carboxykinase (pckA), malate dehydrogenase (mdh), the molecular chaperone trigger factor (tig) and phosphopyruvate hydratase (eno). The immunogenicity of these proteins, however, remains to be evaluated.
In an attempt to identify the optimal harvest time point for PPDj preparation temporal differences in protein secretion of in vitro cultured MAP (CLIJ623) was examined. The number of secreted proteins identified in the cell free culture filtrates increased with age from 72 individual proteins at 20 weeks to 97 proteins at 34 weeks (Additional file 2: Table S2). Interestingly, many proteins identified in the cell-free culture filtrate did not contain a signal peptide and were thus not expected to be secreted. In fact 74% of proteins identified in the cell-free culture filtrate had a signal peptide probability of < 0.5. This finding suggests intracellular proteins are frequently released following cell death and autolysis at these time points. We hypothesised that the secretome is comparable to PPDj, in that PPDj should contain all secretome proteins, as well as some cellular proteins. However, while many of the secreted proteins were also found in PPDj, approximately 20% of these proteins were not observed in PPDj. Furthermore, only 44 proteins were secreted at both time points. This result suggests that PPDj composition may vary significantly depending on the age of the culture. Previously, we have demonstrated that many of the major components of PPDj, such as GroEL2 (hsp65), bacterioferritin and ahpC, are not secreted in large quantities in Mycobacterium avium subsp. avium at either 7 or 14 weeks . In our laboratory Mycobacterium avium subsp. avium PPDa is produced from 13 week cultures and thus may have vast quantitative differences in protein composition compared to PPDj which is produced from 24 week cultures.
Database interrogation revealed that some proteins identified in PPDj had higher sequence coverage to other Mycobacterium species compared to the MAP K10 reference. This situation most likely stems from either incorrectly annotated start open reading frames in MAP K10 or simply that the open reading frame has not been annotated onto the K10 genome at all. Our study identified at least five cases of the latter (Additional file 3: Table S3). Homology searches on the K10 genome revealed six un-annotated open reading frames corresponding to these five proteins. One of these proteins was a glyoxalase/bleomycin resistance protein, closely resembling MAV_1440 in Mycobacterium avium (strain 104). Interestingly, initial mass spectrometry analysis showed this protein to be unique to AAHL PPDj preparations (Additional file 1: Table S1) however, MRM analysis demonstrates that while it is generally more abundant in AAHL PPDj samples, it could also be detected in other PPDj and PPDa preparations (Figure 4D).
This study describes the production and proteomic characterisation of PPDj within our laboratory. The proteomic compositions of the PPDj preparations produced in our laboratory are highly similar to PPDj preparations produced in other institutes/laboratories in terms of general composition. However, considerable differences in absolute abundance of specific proteins were also observed. Compositional differences between PPDj preparations are to some extent a direct reflection of genetic differences between the MAP strain types and indirect temporal changes in growth stages and harvest time point. We strongly advocate the use of a well characterised MAP reference strain, with well described growth dynamics, for all PPDj production globally. Furthermore a standardised harvest time point at 24 weeks will reduce the influence of temporal changes in protein expression thereby generating a more uniform preparation. The immunogenic CLPs identified in across the PPDj preparations should be further evaluated as possible diagnostic targets.
All PPDs produced within our laboratory were derived from an Australian wild type bovine MAP isolate referred to as CLIJ623. This isolate was recovered from the ileocaecal valve of a Jersey cow exhibiting clinical symptoms of the terminal stages of Johne's disease. It was typed as a cattle (Type II) strain by a number of tests: typical colony formation on Herrold's Egg Yolk medium (HEYM) supplemented with mycobactin and sodium pyruvate [32–34], mycobactin dependency, characteristic acid-fast microscopic morphology, PCR detection of the insertion element IS900 and restriction enzyme analysis of IS1311 [23, 35–39]. This isolate has also recently undergone whole genome sequencing . This virulent Australian wild-type strain, with minimal laboratory passage (less than 3 passages), has been used in long term infection time course experiments in cattle, sheep and goats [23–25].
Preparation and source of PPD
List of 15 PPD samples analysed in this study
Canadian Food Inspection Agency
Pfizer Animal Health
National Veterinary Institute
National Veterinary Service Laboratory (USDA)
The in-house PPDj preparation, AAHL1101, was compared to the PPDj preparations produced in Canadian (CAN6) and CSL in its ability to stimulate the IFN-γ response in both Holstein-Friesian cattle and Merino sheep experimentally infected with JD. Blood sample for IFN-γ testing were obtained from previous animal infection experiments described by Stewart et al [23, 25]. Briefly, Holstein-Friesian calves (six weeks of age) or Merino sheep (six months of age) were experimentally infected at weekly intervals for four weeks with either 1 × 1010-2 × 1010 cultured bacteria (bovine MAP strain) or JD infected ileal and distal jejunal mucosal scaping. Previous studies have demonstrated that infection is more easily established with an infected mucosal inoculum compared to a pure bacterial challenge [23–25]. The control groups were dosed with Watson and Reid media without mycobactin. For the purpose of comparing PPDj preparations blood samples taken 45 months post challenge were used. Neither cattle nor sheep demonstrated clinical signs of disease (faecal shedding, loss of body weight and diarrhoea) at this time point. However, positive faecal culture - indicative of a subclinical infection - was observed for both infected cattle and sheep previous to this time point [23, 25].
The IFN-γ assay was performed on duplicate plasma samples with BOVIGAM™ kits following stimulation of blood with either sterile phosphate-buffered saline (nil antigen), Mycobacterium avium PPDa or one of three PPDj samples. The IFN-γ assay was performed exactly as previously described  using whole blood samples obtained from either Holstein-Friesian cattle or Merino sheep experimentally infected with MAP (through either tissue or bacterial inoculum) as described by Stewart et al. [23, 25]. The assays were performed on single plates and the results are reported as optical densities. The response of infected animals to AAHL1101, CSL or CAN6 PPDj was compared using a One-way analysis of variance (ANOVA).
Time course secretome
The composition of secreted MAP proteins within the culture media was investigated at two independent time points. Temporal differences in protein secretion of in vitro cultured MAP may significant influence PPDj composition. The bovine strain CLIJ623 was cultured in modified Watson and Reid (protein free) media as described above. Culture media was harvested at 20 and 34 weeks post inoculation. Media was concentrated using an Amicon filter membrane as previously described . Total protein was quantified for each PPD using the 2-D Quant Kit (GE Healthcare) as per the manufacturer's recommendation. Fifty micrograms of protein was then analysed by LC-MS/MS as described below.
A total of 15 PPD and two secretome samples were analysed by mass spectrometry (Table 3). This included five PPDj preparations prepared within our laboratory and ten additional PPD samples obtained from other institutes/laboratories. These additional PPD preparations were derived from Australia, Canada, The Netherlands, Norway and the USA and were derived from Mycobacterium avium subsp. paratuberculosis (PPDj), Mycobacterium avium subsp. avium (PPDa) and Mycobacterium bovis (PPDb). The PPD preparations (50 μg) were first subjected to reduction with 0.2 mM dithiothreitol (DTT) in 40 mM NH4HCO3 for 2 h at 37°C, followed by alkylation with 50 mM iodoacetamide for 20 mins in the dark at room temperature. PPD proteins were then digested overnight with 2.5 μg of trypsin (protein sequencing grade; Sigma Aldrich) at 37°C. Digestion was terminated by the addition of 0.8% (w/v) formic acid and PPD digests were dried by vacuum centrifugation.
Protein digests were reconstituted in 0.1% formic acid and 1 μg of tryptic peptides were chromatographically resolved using a Shimadzu Prominence LC20 HPLC system with a C18 Vydac column (75 μm × 15 cm, 300 Å, 5 μm). A linear gradient at flow rate of 800 nL/min from 1-40% solvent B over 80 min was utilised where solvent A was 0.1% (w/v) formic acid and solvent B was 0.1% (w/v) formic acid in 90% acetonitrile.
The eluate from the HPLC system was directly coupled to the nanoelectrospray ionisation source of a TripleTOF™ 5600 system (AB/Sciex, Foster City, CA, USA). Data were acquired in information dependent acquisition (IDA) mode. The IDA method consisted of a high resolution TOF-MS survey scan followed by 20 MS/MS in a second with a maximum accumulation time of 50 ms. First stage MS analysis was performed in positive ion mode over the mass range m/z 300-2000 with a 0.5 s accumulation time. The ionspray voltage was set to 2600 V, the curtain gas was set to 25, the nebuliser gas to 20 and the heated interface was set to 150°C. Tandem mass spectra were acquired over the mass range m/z 100-2000 using rolling collision energy (CE) for optimum peptide fragmentation. Precursor ion masses were excluded for 8 s after two occurrences.
Database searching and false discovery rate analysis
All data were processed using ProteinPilot v4.0 with integrated false discovery rate analysis. The spectral sets were searched against all Mycobacteriaceae proteins present in the Uniprot database (version 20110721; 430,740 proteins). Search parameters were defined as cysteine alkylation with iodoacetamide, trypsin as the digestion enzyme and no restrictions were placed on taxonomy. Modifications were set to the "generic workup" and "biological" modification sets provided with this software package, which consisted of all modifications listed in Unimod, for example, acetylation, methylation and phosphorylation. The generic workup modifications set contains 59 potential modifications that may occur as a result of sample handling, for example, oxidation, dehydration and deamidation. The identification of proteins was recorded in the Results section if MS/MS spectral scores were achieved at the p < 0.01 confidence level, i.e. at a 1% global false discovery rate (FDR). Only proteins for which two peptides were identified were considered to be present. Signal peptide probability was determined using SignalP 3.0 .
Multiple reaction monitoring (MRM)
Quantification of individual proteins was compared between PPDj and PPDa preparations based on MRM mass spectrometry analysis. A total of 50 μg of lysozyme C (Sigma-Aldrich) was trypsin digested as described above. Each PPDj and PPDa sample was then spiked with 0.05 μg of digested lysozyme C and analysed on a 4000 QTRAP mass spectrometer (Applied Biosystems, Framingham, MA, USA) equipped with a TurboV ionization source operated in positive ion mode. Samples were chromatographically separated on a Shimadzu Prominence LC20 HPLC system with a C18 Vydac column (75 μm × 15 cm, 300 Å, 5 μm). A linear gradient at flowrate of 800 nL/min from 1-40% solvent B over 20 min was utilised where solvent A was 0.1% formic acid and solvent B was 0.1% (w/v) formic acid in 90% acetonitrile. The eluent from the HPLC was directly coupled to the mass spectrometer. Data were acquired and processed using Analyst 1.5 software™ Quantification of MAP peptides was achieved using scheduled MRM scanning experiments using a 120 s detection window for each MRM transition and a 1 s cycle time. A total of seven target proteins were quantified including four cutinase-like proteins (Locus tags; MAPK_0340, MAPK_0273, MAPK_1748 and MAPK_2088), the acyl-CoA dehydrogenase FadE3_2 (MAPK_0117), a glyoxalase/bleomycin resistance protein (MAV_1440) and the acyl carrier protein acpM (MAPK_1771). For each protein a single peptide was chosen for quantification using the summed area of the two most intense MRM transitions. MRM peak areas were normalised using the MRM peak area of the positive control peptides from lysozyme C (Figure 4A).
Cell mediated immunity
Enzyme-linked immunosorbent assay
Herrold's Egg Yolk medium
Liquid chromatography matrix-assisted laser desorption/ionization
Liquid chromatography tandem mass spectrometry
Mycobacterium avium subspecies avium
Mycobacterium avium subspecies hominissuis
Mycobacterium avium subspecies paratuberculosis
purified protein derivative
The authors wish to thank Dr Jacek Gwoźdź; from the Victorian Department of Primary Industries for valuable advice regarding this manuscript. This study was solely funded by CSIRO.
- Kennedy DJ, Allworth MB: Progress in national control and assurance programs for bovine Johne's disease in Australia. Vet Microbiol 2000, 77: 443–451. 10.1016/S0378-1135(00)00329-1View Article
- Hermon-Taylor J: Mycobacterium aviu subspecies paratuberculosis Crohn's disease and the doomsday scenario. Gut Pathog 2009, 1: 15. 10.1186/1757-4749-1-15View Article
- Kirkwood CD, Wagner J, Boniface K, Vaughan J, Michalski WP, Catto-Smith AG, Cameron DJS, Bishop RF: Mycobacterium aviu subspecies paratuberculosi in children with early-onset Crohn's disease. Inflammatory Bowel Diseases 2009, 15: 1643–1655. 10.1002/ibd.20967View Article
- Wynne JW, Bull TJ, Seemann T, Bulach DM, Wagner J, Kirkwood CD, Michalski WP: Exploring the zoonotic potential of Mycobacterium aviu subspecies paratuberculosi through comparative genomics. PLoS One 2011, 6: e22171. 10.1371/journal.pone.0022171View Article
- Gwozdz JM, Thompson KG, Murray A, Reichel MP, Manktelow BW, West DM: Comparison of three serological tests and an interferon-gamma assay for the diagnosis of paratuberculosis in experimentally infected sheep. Aust Vet J 2000, 78: 779–783. 10.1111/j.1751-0813.2000.tb10452.xView Article
- McDonald WL, Ridge SE, Hope AF, Condron RJ: Evaluation of diagnostic tests for Johne's disease in young cattle. Aust Vet J 1999, 77: 113–119. 10.1111/j.1751-0813.1999.tb11679.xView Article
- Robbe-Austerman S, Gardner IA, Thomsen BV, Morrical DG, Martin BM, Palmer MV, Thoene CO, Ewing C: Sensitivity and specificity of the agar-gel-immunodiffusion test, ELISA and the skin test for detection of paratuberculosis in United States Midwest sheep populations. Veterinary Research 2006, 37: 553–564. 10.1051/vetres:2006018View Article
- Storset AK, Berg I, Djonne B: Evaluation of the gamma interferon test for diagnosis of paratuberculosis in goats. Vet Immunol Immunopathol 2005, 107: 87–94. 10.1016/j.vetimm.2005.03.015View Article
- Sweeney RW, Whitlock RH, Buckley CL, Spencer PA: Evaluation of a Commercial Enzyme-Linked-Immunosorbent-Assay for the Diagnosis of Paratuberculosis in Dairy-Cattle. Journal of Veterinary Diagnostic Investigation 1995, 7: 488–493. 10.1177/104063879500700411View Article
- Robbe-Austerman S, Stabel JR, Palmer MV: Evaluation of the gamma interferon ELISA in sheep subclinically infected with Mycobacterium aviu subspecies paratuberculosi using a whole-cell sonicate or a johnin purified-protein derivative. Journal of Veterinary Diagnostic Investigation 2006, 18: 189–194. 10.1177/104063870601800208View Article
- Stabel JR: Transitions in immune responses to Mycobacterium paratuberculosi . Vet Microbiol 2000, 77: 465–473. 10.1016/S0378-1135(00)00331-XView Article
- Begg DJ, de Silva K, Carter N, Plain KM, Purdie A, Whittington RJ: Does a Th1 over Th2 dominancy really exist in the early stages of Mycobacterium aviu subspecies paratuberculosi infections? Immunobiology 2011, 216: 840–846. 10.1016/j.imbio.2010.12.004View Article
- Wood PR, Jones SL: BOVIGAM (TM): an in vitro cellular diagnostic test for bovine tuberculosis. Tuberculosis 2001, 81: 147–155. 10.1054/tube.2000.0272View Article
- Huda A, Lind P, Christoffersen AB, Jungersen G: Analysis of repeated tests for interferon-gamma (IFN-gamma) response and faecal excretion for diagnosis of subclinical paratuberculosis in Danish cattle. Vet Immunol Immunopathol 2003, 94: 95–103. 10.1016/S0165-2427(03)00063-1View Article
- Jungersen G, Huda A, Hansen JJ, Lind P: Interpretation of the gamma interferon test for diagnosis of subclinical paratuberculosis in cattle. Clin Diagn Lab Immunol 2002, 9: 453–460.
- Borsuk S, Newcombe J, Mendum TA, Dellagostin OA, McFadden J: Identification of proteins from tuberculin purified protein derivative (PPD) by LC-MS/MS. Tuberculosis 2009, 89: 423–430. 10.1016/j.tube.2009.07.003View Article
- Santema W, Overdijk M, Barends J, Krijgsveld J, Rutten V, Koets A: Searching for proteins of Mycobacterium aviu subspecies paratuberculosi with diagnostic potential by comparative qualitative proteomic analysis of mycobacterial tuberculins. Vet Microbiol 2009, 138: 191–196. 10.1016/j.vetmic.2009.03.021View Article
- de Lisle GW, Seguin P, Samagh BS, Corner AH, Duncan JR: Bovine paratuberculosis I. A herd study using complement fixation and intradermal tests. Canadian Journal of Comparative Medicine 1980, 44: 177–182.
- Semret M, Bakker D, Smart N, Olsen I, Haslov K, Behr MA: Genetic analysis of Mycobacterium aviu complex strains used for producing purified protein derivatives. Clinical and Vaccine Immunology 2006, 13: 991–996. 10.1128/CVI.00217-06View Article
- Radosevich TJ, Reinhardt TA, Lippolis JD, Bannantine JP, Stabel JR: Proteome and differential expression analysis of membrane and cytosolic proteins from Mycobacterium aviu subsp. paratuberculosi strains K-10 and 187. J Bacteriol 2007, 189: 1109–1117. 10.1128/JB.01420-06View Article
- Elguezabal N, Bastida F, Sevilla IA, González N, Molina E, Garrido JM, Juste RA: Estimation of Mycobacterium avium subsp. paratuberculosis growth parameters: strain characterization and comparison of methods. Appl Environ Microbiol 2011, 77: 8615–8624. 10.1128/AEM.05818-11View Article
- Mikkelsen H, Aagaard C, Nielsen SS, Jungersen G: Novel antigens for detection of cell mediated immune responses to Mycobacterium aviu subsp paratuberculosi infection in cattle. Vet Immunol Immunopathol 2011, 143: 46–54. 10.1016/j.vetimm.2011.06.022View Article
- Stewart DJ, Vaughan JA, Stiles PL, Noske PJ, Tizard MLV, Prowse SJ, Michalski WP, Butler KL, Jones SL: A long-term study in Merino sheep experimentally infected with Mycobacterium aviu subsp paratuberculosi : clinical disease, faecal culture and immunological studies. Vet Microbiol 2004, 104: 165–178. 10.1016/j.vetmic.2004.09.007View Article
- Stewart DJ, Vaughan JA, Stiles PL, Noske PJ, Tizard MLV, Prowse SJ, Michalski WP, Butler KL, Jones SL: A long-term study in Angora goats experimentally infected with Mycobacterium aviu subsp paratuberculosi : Clinical disease, faecal culture and immunological studies. Vet Microbiol 2006, 113: 13–24. 10.1016/j.vetmic.2005.09.015View Article
- Stewart DJ, Vaughan JA, Stiles PL, Noske PJ, Tizard MLV, Prowse SJ, Michalski WP, Butler KL, Jones SL: A long-term bacteriological and immunological study in Holstein-Friesian cattle experimentally infected with Mycobacterium aviu subsp paratuberculosi and necropsy culture results for Holstein-Friesian cattle, Merino sheep and Angora goats. Vet Microbiol 2007, 122: 83–96. 10.1016/j.vetmic.2006.12.030View Article
- Wynne JW, Seemann T, Bulach D, Coutts SA, Talaat AM, Michalski WP: Resequencing the Mycobacterium aviu subsp. paratuberculosi K10 genome: Improved annotation and revised genome sequence. J Bacteriol 2010, 192: 6319–6320. 10.1128/JB.00972-10View Article
- West NP, Wozniak TM, Valenzuela J, Feng CG, Sher A, Ribeiro JMC, Britton WJ: Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosi . Vaccine 2008, 26: 3853–3859. 10.1016/j.vaccine.2008.05.007View Article
- Olsen I, Reitan LJ, Holstad G, Wiker HG: Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium aviu subsp paratuberculosi . Infection and Immunity 2000, 68: 801–808. 10.1128/IAI.68.2.801-808.2000View Article
- Olsen I, Tryland M, Wiker HG, Reitan LJ: AhpC, AhpD, and a secreted 14-kilodalton antigen from Mycobacterium aviu subsp paratuberculosi distinguish between paratuberculosis and bovine tuberculosis in an enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2001, 8: 797–801.
- Mikkelsen H, Aagaard C, Nielsen SS, Jungersen G: Review of Mycobacterium avium subsp. paratuberculosis antigen candidates with dianostic potential. Vet Microbiol 2001, 152: 1–20.View Article
- Lanigan M, Shiell B, Beddome G, Bruce J, Vaughan J, Stiles P, Tizard M, Stewart D, Michalski WP: Secreted antigens of Mycobacterium aviu subsp. paratuberculosi : identity, characterisation, expression profiles and immunoreactivity. Current Topics in Peptide and Protein Research 2007, 8: 67–79.
- Herrold RD: Egg yolk agar medium for the growth of tubercle bacilli. J Infect Dis 1931, 48: 236–241. 10.1093/infdis/48.2.236View Article
- Merkal RS, McCullough WC: A new mycobactin, Mycobactin J, from Mycobacterium paratuberculosi . Curr Microbiol 1982, 7: 33–35.View Article
- Merkal RS, Whipple DL, Sacks JM, Snyder GR: Prevalence of Mycobacterium paratuberculosi in ileocecal lymph-nodes of cattle culled in the United-States. J Am Vet Med Assoc 1987, 190: 676–680.
- Collins DM, Gabric DM, de Lisle GW: Identification of two groups of Mycobacterium paratuberculosi strains by restriction endonuclease analysis and DNA hybridization. J Clin Microbiol 1990, 28: 1591–1596.
- Collins DM, Gabric DM, De Lisle GW: Identification of a repetitive DNA sequence specific to Mycobacterium paratuberculosi . FEMS Microbiol Lett 1990, 60: 175–178.View Article
- Cousins DV, Evans RJ, Francis BR: Use of BACTEC radiometric culture method and polymerase chain reaction for the rapid screening of faeces and tissues for Mycobacterium paratuberculosi . Aust Vet J 1995, 72: 458–462. 10.1111/j.1751-0813.1995.tb03489.xView Article
- Cousins DV, Williams SN, Hope A, Eamens GJ: DNA fingerprinting of Australian isolates of Mycobacterium aviu subsp paratuberculosi using IS900 RFLP. Aust Vet J 2000, 78: 184–190. 10.1111/j.1751-0813.2000.tb10590.xView Article
- Whittington RJ, Hope AF, Marshall DJ, Taragel CA, Marsh I: Molecular epidemiology of Mycobacterium aviu subsp paratuberculosi : IS900 restriction fragment length polymorphism and IS1311 polymorphism analyses of isolates from animals and a human in Australia. J Clin Microbiol 2000, 38: 3240–3248.
- Morrison NE: Circumvention of mycobactin requirement of Mycobacterium paratuberculosis . J Bacteriol 1965, 89: 762–767.
- Bendtsen JD, Nielsen H, von Heijne G, Brunak S: Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340: 783–795. 10.1016/j.jmb.2004.05.028View Article
- Li LL, Bannantine JP, Zhang Q, Amonsin A, May BJ, Alt D, Banerji N, Kanjilal S, Kapur V: The complete genome sequence of Mycobacterium aviu subspecies paratuberculosi . Proceedings of the National Academy of Sciences of the United States of America 2005, 102: 12344–12349. 10.1073/pnas.0505662102View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.